Insights from the Molecular Docking of Hydrolytic Products of Methyl Isocyanate (MIC) to Inhibition of Human Immune Proteins
- 202 Downloads
This study is an attempt to find the reason for immunological suppression in victims of Bhopal gas tragedy during 1984 against Mycobacterium tuberculosis (Mtb) infection. Here, we tried to understand this problem by studying interactions between immune proteins associated with susceptibility to tuberculosis and hydrolytic products of methyl isocyanate (MIC) released during the tragedy. The hydrolytic products of MIC i.e. dimethyl urea, trimethyl urea and trimethyl isocyanurate were docked to different human immune proteins against Mtb using AutoDock 4.0. Results shows that all hydrolytic products (dimethyl urea, trimethyl urea and trimethylisocyanurate) strongly inhibit to CD40 ligand, and their binding energies were found to be \(\Delta\)G\(-\)3.51, \(-\)3.79, \(-\)4.55 (Kcal/mole), respectively. Further, to check the stability of docked complex, we performed the molecular dynamics simulation study which also shows that CD40 Ligand was maximally inhibited by trimethylisocyanurate and has a role in the macrophage activation for the destruction of M. tuberculosis. The present study may lead to better understanding of human immune protein inhibition by hydrolytic product of MIC.
KeywordsMethyl isocyanate Hydrolytic product Mycobacterium tuberculosis Molecular docking Immune suppression
- 1.Shrivastava R, Punde RP, Deshpande S (2010) Molecular characterization and bioinformatics approach of tuberculosis infection prevalent in methyl isocyanate affected population in Bhopal. Pharmacologyonline 3:757–767Google Scholar
- 9.Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (2007) AutoDock, Version 4.0.1: The Scripps Research Institute, La Jolla Google Scholar
- 15.Schuttelkopf AW, Van Aalten DMF (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Cryst 60:1355–1363Google Scholar
- 18.Hewison M (2012) An update on Vitamin D and human immunity. ClinEndocrinol 76(3):315–325Google Scholar